Beneficial effect of probiotics supplements in reflux esophagitis treated with esomeprazole: A randomized controlled trial

Figure 5 Proportion of patients without small intestinal bacterial overgrowth at the beginning and endpoint of follow-up. Probiotics refers to esomeprazole 20 mg b.i.d. and live combined Bacillus subtilis and Enterococcus faecium enteric-coated capsules 500 mg t.i.d. treatment; placebo refers to esomeprazole 20 mg b.i.d. and placebo treatment. ^aP < 0.05; ^bP < 0.01; ^cP < 0.001. SIBO: Small intestinal bacterial overgrowth.